The cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improve when ...

According to DelveInsight’s analysis, the human papillomavirus market is anticipated to increase during the forecast period (2024–2034), owing to the launch of emerging therapies and healthcare ...

According to a report, nine types of Human papillomavirus (HPV) are accountable for almost 98.4 per cent of total cervical ...

"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

Human papillomavirus or HPV, causes plantar warts that are small, rough growths on the feet and usually show up on the balls ...

For starters, it does not mean you have cancer—or that you’re destined to develop it.

This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This cohort of women is the first to be widely protected against cervical ...

While the HPV vaccine is often marketed in Iowa toward women, a health care professional says it’s important that young ...

In order to one day eliminate cervical cancer, the World Health Organization has set out a global strategy: 90 percent of girls to be vaccinated by the age of 15; 70 percent of women screened by the ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...